|
 |
Home
|
|
 |
|
Director's Letter
|
|
|
History of the Program and Accomplishments
|
|
|
Description of the Program
|
|
|
Resources and Environment
|
|
|
Children's Hospital
|
|
|
Basic Research Faculty
|
|
|
GI Cell Biology Laboratories
|
|
|
Harvard Digestive Diseases Center
|
|
|
Graduate Programs at Harvard & MIT
|
|
|
Clinical Research Faculty
|
|
|
|
Afdhal, Nezam H.
|
|
|
|
Austin, S. Bryn
|
|
|
|
Christiani, David C.
|
|
|
|
Cook, E. Francis
|
|
|
|
Duggan, Christopher P.
|
|
|
|
Fawzi, Wafaie W.
|
|
|
|
Finkelstein, Jonathan A.
|
|
|
|
Gillman, Matthew W.
|
|
|
|
Goldmann, Donald A.
|
|
|
|
Gordon, Catherine M.
|
|
|
|
Grand, Richard J.
|
|
|
|
Grinspoon, Steven K.
|
|
|
|
Jaksic, Tom
|
|
|
|
Klibanski, Anne
|
|
|
|
Lightdale, Jenifer R.
|
|
|
|
Ludwig, David S.
|
|
|
|
Newburger, Jane W.
|
|
|
|
Nurko, Samuel S.
|
|
|
|
Osganian, Stavroula K.
|
|
|
|
Rufo, Paul A.
|
|
|
|
Sands, Bruce E.
|
|
|
|
Willett, Walter C.
|
|
|
|
Center for Inflammatory Bowel Disease
|
|
|
Master Degree Programs in Clinical Research
|
|
|
General Clinical Research Centers
|
|
|
Current Fellows
|
|
|
Alumni
|
|
|
Application Process and Forms
|
|
|
Benefits
|
|
|
Program Materials
|
|
|
|
|
|
Nezam H. Afdhal, MD
|
|
Division of Gastroenterology, Beth Israel Deaconess Medical Center
|
|
|
Beth Israel Deaconess Medical Center
110 Francis Street
Suite 8E
Boston, MA 02215
Phone: 617-632-1070
Fax: 617-632-1065
Email: nafdhal@bidmc.havard.edu
Research Interests
My research program is focused on translational activities involving novel biomarkers for liver fibrosis and liver cancer. These are NIH funded translational studies looking at proteomics and novel markers for HCC. In addition, we have developed a core fibrosis laboratory that is working on translational studies of novel biomarkers for NASH and HCV induced liver fibrosis. These assays will be utilized in NIH clinical trials such a sthse for silymarin, SYNCH-C and also in industry sponsored studies. In addition, we have a basic science laboratory that is studying the physical chemical properties of gastric mucin and mucin peptides.
Selected Publications
Kamal SM, Fouly AE, Kamel RR, Hockenjos B, Al Tawil A, Khalifa KE, He Q, Koziel MJ, El Naggar KM, Rasenack J, Afdhal NH. Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response. Gastroenterology. 2006;130(3):632-638.
Kamal SM, Turner B, He Q, Rasenack J, Bianchi L, Al Tawil A, Nooman A, Massoud M, Koziel MJ, Afdhal NH. Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis. Hepatology. 2006;43(4):771-779.
Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL. Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology. 2006;43(4):788-95.
|
|
|
|
|
|
|
